Indeed, studies in mice report that IGF-1/ LR3 is eliminated entirely within 4 hours of intramuscular injection, meaning its half-life in mice is less than 1 hour

Pre-treatment: Measure morning resting heart rate for 7 days Consider baseline ECG if not done recently Review all medications for cardiac interactions Discuss with physician specifically about the glucagon receptor heart rate effect During treatment: Measure resting heart rate daily during dose escalation Continue at each dose for minimum 6 to 8 weeks before increasing If resting HR exceeds baseline by more than 10 BPM, hold dose If resting HR exceeds 90 BPM at rest consistently, consult physician before any further increases Consider microdosing approach for ultra-gradual escalation Expected timeline: Weeks 1-12: very gradual heart rate change at low doses Weeks 12-30: moderate increase as dose slowly climbs Weeks 30+: stabilization (may occur later than standard protocol due to slower escalation) Protocol 3: monitoring-enhanced approach for data-driven researchers Who this is for: Researchers who want comprehensive data, athletes tracking performance metrics, anyone who finds data reassuring

2019;317:C13249
You can ask if the pharmacy follows USP (United States Pharmacopeia) standards for sterile compounding and whether they perform third-party testing for potency and purity on their products
Switching from Wegovy Pill to the Injection If you are switching from the Wegovy pill to the injection, you can usually start the injection the day after taking your last pill dose
A small number of patients report mild reactions including nausea, slight discomfort at the injection site, or temporary tiredness